A Rumored Acquisition Could Shake up Orthopedics

Globus Medical could be looking into acquiring Nuvasive, according to a Reuters report.

Omar Ford

November 16, 2021

1 Min Read
IMG_Nov162021at15916PM.jpg
Zoonar GmbH / Alamy Stock Photo

A rumored acquisition in the orthopedics space has the potential to significantly strengthen one company’s competitive prowess. Globus Medical is rumored to be looking to acquire San Diego, CA-based Nuvasive, a spine surgery company, according to a report from Reuters, citing people familiar with the matter.

The Reuters report goes on to say that discussions between the companies were preliminary and that there is no certainty that a deal will be reached.

Nuvasive kicked off 2021 with some M&A of its own. The company added a differentiated cervical disc to its product portfolio through a $150 million acquisition of Simplify Medical. 

Now, Nuvasive finds itself in a spot that is like many orthopedics companies these days. The firm has had to fight for stability since the COVID-19 outbreak.

The spine company lowered its FY21 revenue guidance from $1.132 billion-$1.142B from $1.19 billion-$1.21 billion previously. Ryan Zimmerman, an analyst with BTIG, said the year-over-year decline in net sales in 3Q was a combination of Delta and staffing shortage impacts on elective procedures and limited NSO product availability.

“We believe that beyond the COVID crisis, a return to improved results in biologics and NCS could boost US Surgical Support, and new product introductions in cervical and open spine surgery are not considered,” Zimmerman wrote in a research note.

About the Author

Omar Ford

Omar Ford is a veteran reporter in the field of medical technology and healthcare journalism. As Editor-in-Chief of MD+DI (Medical Device and Diagnostics Industry), a leading publication in the industry, Ford has established himself as an authoritative voice and a trusted source of information.

Ford, who has a bachelor's degree in print journalism from the University of South Carolina, has dedicated his career to reporting on the latest advancements and trends in the medical device and diagnostic sector.

During his tenure at MD+DI, Ford has covered a wide range of topics, including emerging medical technologies, regulatory developments, market trends, and the rise of artificial intelligence. He has interviewed influential leaders and key opinion leaders in the field, providing readers with valuable perspectives and expert analysis.

 

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like